These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 34362853)

  • 81. Significance of gray matter brain lesions in multiple sclerosis and neuromyelitis optica.
    Kawachi I; Nishizawa M
    Neuropathology; 2015 Oct; 35(5):481-6. PubMed ID: 26079808
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Choroid Plexus Volume in Multiple Sclerosis vs Neuromyelitis Optica Spectrum Disorder: A Retrospective, Cross-sectional Analysis.
    Müller J; Sinnecker T; Wendebourg MJ; Schläger R; Kuhle J; Schädelin S; Benkert P; Derfuss T; Cattin P; Jud C; Spiess F; Amann M; Lincke T; Barakovic M; Cagol A; Tsagkas C; Parmar K; Pröbstel AK; Reimann S; Asseyer S; Duchow A; Brandt A; Ruprecht K; Hadjikhani N; Fukumoto S; Watanabe M; Masaki K; Matsushita T; Isobe N; Kira JI; Kappos L; Würfel J; Granziera C; Paul F; Yaldizli Ö
    Neurol Neuroimmunol Neuroinflamm; 2022 May; 9(3):. PubMed ID: 35217580
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Lesions of the posterior limb of the internal capsule in neuromyelitis optica spectrum disorder.
    Long Y; Wu L; Zhong R; Ouyang X; Liang J; Gao C; Chen X; Qiu W; Chang Y; Wang Z; Ye J
    Neurol Res; 2017 May; 39(5):448-452. PubMed ID: 28262035
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Diagnostic algorithm for relapsing acquired demyelinating syndromes in children.
    Hacohen Y; Mankad K; Chong WK; Barkhof F; Vincent A; Lim M; Wassmer E; Ciccarelli O; Hemingway C
    Neurology; 2017 Jul; 89(3):269-278. PubMed ID: 28615429
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Cerebrospinal fluid findings in aquaporin-4 antibody positive neuromyelitis optica: results from 211 lumbar punctures.
    Jarius S; Paul F; Franciotta D; Ruprecht K; Ringelstein M; Bergamaschi R; Rommer P; Kleiter I; Stich O; Reuss R; Rauer S; Zettl UK; Wandinger KP; Melms A; Aktas O; Kristoferitsch W; Wildemann B
    J Neurol Sci; 2011 Jul; 306(1-2):82-90. PubMed ID: 21550068
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Optimal management of neuromyelitis optica spectrum disorder with aquaporin-4 antibody by oral prednisolone maintenance therapy.
    Takai Y; Kuroda H; Misu T; Akaishi T; Nakashima I; Takahashi T; Nishiyama S; Fujihara K; Aoki M
    Mult Scler Relat Disord; 2021 Apr; 49():102750. PubMed ID: 33524925
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Diagnostic value of bright spotty lesions on MRI after a first episode of acute myelopathy.
    Rabasté S; Cobo-Calvo A; Nistiriuc-Muntean V; Vukusic S; Marignier R; Cotton F;
    J Neuroradiol; 2021 Feb; 48(1):28-36. PubMed ID: 32407908
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Bone health in neuromyelitis optica: Bone mineral density and fractures.
    Kwon YN; Im SY; Park YS; Ahn SH; Seo J; Kim SB; Yoon SS; Waters P; Choi HJ; Kong SH; Sung JJ; Kim SM; Park KS
    Mult Scler Relat Disord; 2020 Jul; 42():102080. PubMed ID: 32497999
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Eye movement abnormalities in AQP4-IgG positive neuromyelitis optica spectrum disorder.
    Sun H; Cui S; Gao F; You Q; Li Y; Wang J; Zhang X
    J Neurol Sci; 2018 Jan; 384():91-95. PubMed ID: 29249386
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Distinction of seropositive NMO spectrum disorder and MS brain lesion distribution.
    Matthews L; Marasco R; Jenkinson M; Küker W; Luppe S; Leite MI; Giorgio A; De Stefano N; Robertson N; Johansen-Berg H; Evangelou N; Palace J
    Neurology; 2013 Apr; 80(14):1330-7. PubMed ID: 23486868
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Epidemiological findings of neuromyelitis optica spectrum disorders in a Venezuelan study.
    Ibis SC; Omaira M; Arnoldo S; Elizabeth A; Sandra M; Carlota CM; Elizabeth C; Laura V; Rosalba L; Oscar V; Luisa DM; Nahir A; Hernandez F
    Mult Scler Relat Disord; 2021 Jan; 47():102652. PubMed ID: 33279797
    [TBL] [Abstract][Full Text] [Related]  

  • 92. A comparative optical coherence tomography study in neuromyelitis optica spectrum disorder and multiple sclerosis.
    Outteryck O; Majed B; Defoort-Dhellemmes S; Vermersch P; Zéphir H
    Mult Scler; 2015 Dec; 21(14):1781-93. PubMed ID: 25828758
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Pregnancy-related relapse risk factors in women with anti-AQP4 antibody positivity and neuromyelitis optica spectrum disorder.
    Shimizu Y; Fujihara K; Ohashi T; Nakashima I; Yokoyama K; Ikeguch R; Takahashi T; Misu T; Shimizu S; Aoki M; Kitagawa K
    Mult Scler; 2016 Oct; 22(11):1413-1420. PubMed ID: 25921053
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Frequency of brain MRI abnormalities in neuromyelitis optica spectrum disorder at presentation: A cohort of Latin American patients.
    Carnero Contentti E; Daccach Marques V; Soto de Castillo I; Tkachuk V; Antunes Barreira A; Armas E; Chiganer E; de Aquino Cruz C; Di Pace JL; Hryb JP; Lavigne Moreira C; Lessa C; Molina O; Perassolo M; Soto A; Caride A
    Mult Scler Relat Disord; 2018 Jan; 19():73-78. PubMed ID: 29156226
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Modified models to distinguish central nervous system demyelinating diseases with brain lesions.
    Chen B; Qin C; Ji S; Tian D; Zhang M; Bu B
    Mult Scler Relat Disord; 2021 Jul; 52():102965. PubMed ID: 33905981
    [TBL] [Abstract][Full Text] [Related]  

  • 96. Presence of anti-Ro/SSA antibody may be associated with anti-aquaporin-4 antibody positivity in neuromyelitis optica spectrum disorder.
    Park JH; Hwang J; Min JH; Kim BJ; Kang ES; Lee KH
    J Neurol Sci; 2015 Jan; 348(1-2):132-5. PubMed ID: 25500159
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [The clinical analyses of neuromyelitis optica spectrum disorder initially presenting with area postrema syndrome in 14 patients].
    Guo QF; Song DD; Wang QQ; Wang ZW; Liu JG; Qi XK
    Zhonghua Nei Ke Za Zhi; 2017 May; 56(5):358-362. PubMed ID: 28460507
    [No Abstract]   [Full Text] [Related]  

  • 98. A prospective study on tryptophan immunoadsorption in AQP4 antibody-positive neuromyelitis optica spectrum disorders.
    Liu J; Zhou R; Gong Y; Ding X; Huang Q; Zhang Y; Feng Y; Wang D; Zhou H; Ma Y; Zhang X; Zhou Y
    J Clin Apher; 2022 Jun; 37(3):237-244. PubMed ID: 35104012
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Condition-dependent generation of aquaporin-4 antibodies from circulating B cells in neuromyelitis optica.
    Wilson R; Makuch M; Kienzler AK; Varley J; Taylor J; Woodhall M; Palace J; Leite MI; Waters P; Irani SR
    Brain; 2018 Apr; 141(4):1063-1074. PubMed ID: 29447335
    [TBL] [Abstract][Full Text] [Related]  

  • 100. AQP4-IgG-seropositive neuromyelitis optica spectrum disorder (NMOSD) coexisting with anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis: A case report and literature review.
    Tao S; Zhang Y; Ye H; Guo D
    Mult Scler Relat Disord; 2019 Oct; 35():185-192. PubMed ID: 31398657
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.